Literature DB >> 11274403

Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 alpha.

M Nagai1, S Tanaka, M Tsuda, S Endo, H Kato, H Sonobe, A Minami, H Hiraga, H Nishihara, H Sawa, K Nagashima.   

Abstract

Human synovial sarcoma has been shown to exclusively harbor the chromosomal translocation t(X;18) that produces the chimeric gene SYT-SSX. However, the role of SYT-SSX in cellular transformation remains unclear. In this study, we have established 3Y1 rat fibroblast cell lines that constitutively express SYT, SSX1, and SYT-SSX1 and found that SYT-SSX1 promoted growth rate in culture, anchorage-independent growth in soft agar, and tumor formation in nude mice. Deletion of the N-terminal 181 amino acids of SYT-SSX1 caused loss of its transforming activity. Furthermore, association of SYT-SSX1 with the chromatin remodeling factor hBRM/hSNF2 alpha, which regulates transcription, was demonstrated in both SYT-SSX1-expressing 3Y1 cells and in the human synovial sarcoma cell line HS-SY-II. The binding region between the two molecules was shown to reside within the N-terminal 181 amino acids stretch (aa 1--181) of SYT-SSX1 and 50 amino acids (aa 156--205) of hBRM/hSNF2 alpha and we found that the overexpression of this binding region of hBRM/hSNF2 alpha significantly suppressed the anchorage-independent growth of SYT-SSX1-expressing 3Y1 cells. To analyze the transcriptional regulation by SYT-SSX1, we established conditional expression system of SYT-SSX1 and examined the gene expression profiles. The down-regulation of potential tumor suppressor DCC was observed among 1,176 genes analyzed by microarray analysis, and semi-quantitative reverse transcription--PCR confirmed this finding. These data clearly demonstrate transforming activity of human oncogene SYT-SSX1 and also involvement of chromatin remodeling factor hBRM/hSNF2 alpha in human cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274403      PMCID: PMC31140          DOI: 10.1073/pnas.061036798

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling.

Authors:  K Zhao; W Wang; O J Rando; Y Xue; K Swiderek; A Kuo; G R Crabtree
Journal:  Cell       Date:  1998-11-25       Impact factor: 41.582

2.  Another synovial sarcoma with t(X;18)

Authors:  S Wang-Wuu; S W Soukup; B J Lange
Journal:  Cancer Genet Cytogenet       Date:  1987-11

3.  Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF.

Authors:  H S Zhang; M Gavin; A Dahiya; A A Postigo; D Ma; R X Luo; J W Harbour; D C Dean
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

4.  mRNA profiling of rat islet tumors reveals nkx 6.1 as a beta-cell-specific homeodomain transcription factor.

Authors:  J Jensen; P Serup; C Karlsen; T F Nielsen; O D Madsen
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

5.  Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor.

Authors:  H Chiba; M Muramatsu; A Nomoto; H Kato
Journal:  Nucleic Acids Res       Date:  1994-05-25       Impact factor: 16.971

6.  Identification of a chromosome 18q gene that is altered in colorectal cancers.

Authors:  E R Fearon; K R Cho; J M Nigro; S E Kern; J W Simons; J M Ruppert; S R Hamilton; A C Preisinger; G Thomas; K W Kinzler
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

7.  A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas.

Authors:  F L Lim; M Soulez; D Koczan; H J Thiesen; J C Knight
Journal:  Oncogene       Date:  1998-10-15       Impact factor: 9.867

8.  Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma.

Authors:  J Clark; P J Rocques; A J Crew; S Gill; J Shipley; A M Chan; B A Gusterson; C S Cooper
Journal:  Nat Genet       Date:  1994-08       Impact factor: 38.330

9.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.

Authors:  I Versteege; N Sévenet; J Lange; M F Rousseau-Merck; P Ambros; R Handgretinger; A Aurias; O Delattre
Journal:  Nature       Date:  1998-07-09       Impact factor: 49.962

10.  Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma.

Authors:  A J Crew; J Clark; C Fisher; S Gill; R Grimer; A Chand; J Shipley; B A Gusterson; C S Cooper
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

View more
  46 in total

1.  The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway.

Authors:  Roy Barco; Laura B Hunt; Andrea L Frump; Christina B Garcia; Andrew Benesh; Robert L Caldwell; Josiane E Eid
Journal:  Mol Biol Cell       Date:  2007-08-08       Impact factor: 4.138

2.  Primary Renal Synovial Sarcoma and Clinical and Pathological Findings: a Systematic Review.

Authors:  Leandro Blas; Javier Roberti
Journal:  Curr Urol Rep       Date:  2021-03-11       Impact factor: 3.092

3.  Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics.

Authors:  Le Su; Arthur V Sampaio; Kevin B Jones; Marina Pacheco; Angela Goytain; Shujun Lin; Neal Poulin; Lin Yi; Fabio M Rossi; Juergen Kast; Mario R Capecchi; T Michael Underhill; Torsten O Nielsen
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

4.  ANGUSTIFOLIA3 binds to SWI/SNF chromatin remodeling complexes to regulate transcription during Arabidopsis leaf development.

Authors:  Liesbeth Vercruyssen; Aurine Verkest; Nathalie Gonzalez; Ken S Heyndrickx; Dominique Eeckhout; Soon-Ki Han; Teddy Jégu; Rafal Archacki; Jelle Van Leene; Megan Andriankaja; Stefanie De Bodt; Thomas Abeel; Frederik Coppens; Stijn Dhondt; Liesbeth De Milde; Mattias Vermeersch; Katrien Maleux; Kris Gevaert; Andrzej Jerzmanowski; Moussa Benhamed; Doris Wagner; Klaas Vandepoele; Geert De Jaeger; Dirk Inzé
Journal:  Plant Cell       Date:  2014-01-17       Impact factor: 11.277

5.  ATR Is a Therapeutic Target in Synovial Sarcoma.

Authors:  Samuel E Jones; Emmy D G Fleuren; Jessica Frankum; Asha Konde; Chris T Williamson; Dragomir B Krastev; Helen N Pemberton; James Campbell; Aditi Gulati; Richard Elliott; Malini Menon; Joanna L Selfe; Rachel Brough; Stephen J Pettitt; Wojciech Niedzwiedz; Winette T A van der Graaf; Janet Shipley; Alan Ashworth; Christopher J Lord
Journal:  Cancer Res       Date:  2017-10-16       Impact factor: 12.701

6.  The effect of SYT-SSX and extracellular signal-regulated kinase (ERK) on cell proliferation in synovial sarcoma.

Authors:  Wenjuan Cai; Yan Sun; Wei Wang; Chunrong Han; Mamoru Ouchida; Wenbin Xia; Xiulan Zhao; Baocun Sun
Journal:  Pathol Oncol Res       Date:  2011-01-14       Impact factor: 3.201

Review 7.  Synovial sarcoma: from genetics to genetic-based animal modeling.

Authors:  Malay Haldar; R Lor Randall; Mario R Capecchi
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

8.  Identification of target genes for wild type and truncated HMGA2 in mesenchymal stem-like cells.

Authors:  Jørn Henriksen; Marianne Stabell; Leonardo A Meza-Zepeda; Silje Au Lauvrak; Moustapha Kassem; Ola Myklebost
Journal:  BMC Cancer       Date:  2010-06-25       Impact factor: 4.430

9.  The synovial sarcoma-associated SYT-SSX2 oncogene antagonizes the polycomb complex protein Bmi1.

Authors:  Roy Barco; Christina B Garcia; Josiane E Eid
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

10.  Epigenetic features of human mesenchymal stem cells determine their permissiveness for induction of relevant transcriptional changes by SYT-SSX1.

Authors:  Luisa Cironi; Paolo Provero; Nicola Riggi; Michalina Janiszewska; Domizio Suva; Mario-Luca Suva; Vincent Kindler; Ivan Stamenkovic
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.